You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Insulin degrading enzyme / IDE antibody - Carboxyterminal end (ab39889)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Insulin degrading enzyme / IDE antibody - Carboxyterminal end
See all Insulin degrading enzyme / IDE products (11) ...

Description

Rabbit polyclonal to Insulin degrading enzyme / IDE - Carboxyterminal end

Specificity

The antibody recognizes the metalloproteinase Insulysin.

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat

Immunogen

Synthetic peptide based on the carboxyterminal end of Human Insulin degrading enzyme / IDE. (Peptide available as ab41261.)

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

The antibody has been peptide affinity purified and concentrated.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Insulin degrading enzyme / IDE antibody (ab39889)Western blot - Insulin degrading enzyme / IDE antibody (ab39889) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab39889 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates. Predicted molecular weight: 118 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia.

Sequence similarities

Belongs to the peptidase M16 family.

Post-translational
modifications

The N-terminus is blocked.

Cellular localization

Cytoplasm. Cell surface. Present at the cell surface of neuron cells. The membrane-associated isoform is approximately 5 kDa larger than the known cytosolic isoform.

Target information above from: UniProt accessionP14735 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Abeta-degrading protease antibody
  • FLJ35968 antibody
  • Ide antibody
  • IDE_HUMAN antibody
  • insulin protease antibody
  • Insulin-degrading enzyme antibody
  • insulinase antibody
  • insulysin antibody
  • OTTHUMP00000020097 antibody
see all

Anti-Insulin degrading enzyme / IDE antibody - Carboxyterminal end images:

  Western blot - Insulin degrading enzyme / IDE antibody (ab39889)

Western blot - Insulin degrading enzyme / IDE antibody (ab39889)

All lanes : Anti-Insulin degrading enzyme / IDE antibody - Carboxyterminal end (ab39889) at 1/1000 dilution

Lane 1 : Insulysin at 0.05 µg
Lane 2 : Insulysin at 0.01 µg
Lane 3 : Insulysin at 0.001 µg


Predicted band size : 118 kDa
Observed band size : 110 kDa (why is the actual band size different from the predicted?)
Additional bands at : 47 kDa (possible cleavage fragment).

References for Anti-Insulin degrading enzyme / IDE antibody - Carboxyterminal end (ab39889)

This product has been referenced in:

  • Cauševic Met al. ß-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration. Neurosci Lett 485:162-6 (2010). Read more (PubMed: 20826196) »

See 1 publication for this product

Publishing research using ab39889? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"